The positive reaction in after-hours trading was driven by HIMS's impressive earnings, with revenues nearing the $600 million mark. From a technical analysis perspective, all eyes are now on the 200-day Moving Average. The critical test will be whether the stock can successfully break through and reclaim this level from below. If it succeeds, the price would re-enter its former trading range, creating a promising setup for a future upward breakout.
On the downside, a failure to overcome the 200-day MA could lead to a pullback. The most likely target in that scenario would be the $37.45 level, which aligns with the 0.618 Fibonacci retracement and has proven to be a reliable support zone in the past.
My investment stance remains firmly long-term. The company's solid fundamentals, underscored by newly announced growth initiatives and a strategic global expansion into markets like Europe, Brazil, and Australia, provide strong conviction to hold through near-term price fluctuations. KalaGhazii
Support and Resistance -
Support - $37.50 - $40.00
Resistance - $60 - $65
On the downside, a failure to overcome the 200-day MA could lead to a pullback. The most likely target in that scenario would be the $37.45 level, which aligns with the 0.618 Fibonacci retracement and has proven to be a reliable support zone in the past.
My investment stance remains firmly long-term. The company's solid fundamentals, underscored by newly announced growth initiatives and a strategic global expansion into markets like Europe, Brazil, and Australia, provide strong conviction to hold through near-term price fluctuations. KalaGhazii
Support and Resistance -
Support - $37.50 - $40.00
Resistance - $60 - $65
Haftungsausschluss
Die Informationen und Veröffentlichungen sind nicht als Finanz-, Anlage-, Handels- oder andere Arten von Ratschlägen oder Empfehlungen gedacht, die von TradingView bereitgestellt oder gebilligt werden, und stellen diese nicht dar. Lesen Sie mehr in den Nutzungsbedingungen.
Haftungsausschluss
Die Informationen und Veröffentlichungen sind nicht als Finanz-, Anlage-, Handels- oder andere Arten von Ratschlägen oder Empfehlungen gedacht, die von TradingView bereitgestellt oder gebilligt werden, und stellen diese nicht dar. Lesen Sie mehr in den Nutzungsbedingungen.